Exercise effects on blood vesicles and fitness in adults with overweight or obesity
Official title: Exploring the Impact of Exercise-derived Extracellular Vesicle in Blood and Physical Fitness Data in Overweight/Obesity Individuals on Lymphangiogenesis
Run by Mahidol University · NCT07312344 · Data updated 2026-11-12
This project will test whether high-intensity interval treadmill exercise changes small particles in the blood (extracellular vesicles) and improves physical fitness in Thai adults aged 25–45 with overweight or obesity.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 45 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Mahidol University Academic / other |
| Locations | 1 site (Mueang Samut Prakan) |
| Status | Recruiting |
| Started | August 30, 2025 |
| Main results expected | January 31, 2026 |
| Study ends | January 31, 2026 |
| Registry record updated | December 31, 2025 |
| Trial ID | NCT07312344 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Thai men and women aged 25–45 with BMI 25–35 who lead a sedentary lifestyle and can walk without assistive devices.
✕Probably not a fit
People who smoke, have substance or alcohol addiction, have a history of respiratory or cardiovascular disease, or who are outside the specified age or BMI ranges are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center interventional study will enroll Thai adults aged 25–45 with BMI 25–35 who report low physical activity to complete a program of high-intensity interval training on a treadmill. Blood samples will be collected before and after exercise sessions to measure extracellular vesicles and other blood components, and standardized physical fitness tests will track functional changes. Participants will be screened to exclude smokers, people with substance or alcohol addiction, and those with major respiratory or cardiovascular disease. The aim is to link exercise-induced changes in blood markers with measurable fitness improvements to inform prevention strategies, drug development, and health-promotion programs.
Why it matters
Potential benefit: If successful, the findings could identify blood markers and exercise approaches that help tailor prevention programs or therapies for people with overweight or obesity.
How similar studies have gone: Previous research shows exercise can alter extracellular vesicle profiles and improve fitness in other groups, but applying HIIT with focused EV analysis in overweight Thai adults is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female individuals aged between 25-45 years 2. Thai nationality 3. Ability to walk or perform daily activities independently, without the use of an assistive device 4. Body mass index (BMI) between 25-35 kg/m² 5. Low physical activity levels or sedentary lifestyle based on the World Health Organization 2020 * The levels of moderate-intensity physical activity \< 150-300 minutes per week or the levels of vigorous-intensity physical activity \< 75-150 minutes per week * Moderate-intensity physical activity: fast walking and bicycling. Vigorous-intensity physical activity: running, aerobic dance, and swimming All participants are required to meet all inclusion criteria to be eligible for the research project. Exclusion Criteria: 1. Smoking, substance abuse, or alcohol addiction 2. History of respiratory diseases, such as asthma, emphysema, or chronic obstructive pulmonary disease 3. History of cardiovascular diseases, such as coronary heart disease, aortic disease, arrhythmia, or deep vein thrombosis 4. History of high blood pressure (hypertension) 5. History of vestibular system diseases, such as Meniere's disease or otitis media 6. History of neurological disease, such as severe Parkinson's disease or stroke 7. History of previous lower limb surgery, such as hip, knee, or ankle replacement 8. History of musculoskeletal diseases, such as severe osteoarthritis 9. History of severe brain disease, such as dementia 10. Severe visual or hearing impairment 11. Have a cognitive and comprehensive impairment and unable to complete the intervention 12. Have high physical activity or regularly exercise
Where it's running
-
Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital
Mueang Samut Prakan, Thailand Recruiting
Study contacts
- Study coordinator: Onaong Mee-inta, Ph.D.
- Email: onanong.mee@mahidol.ac.th
- Phone: (66)619922941
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How incretin treatments affect muscle mass and function in people with overweight or obesity
This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.
-
Dose find for remimazolam plus alfentanil for gastroscopy in obese adults
This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.
-
Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults
This study compares how much weight adults lose over two years when starting GLP-1 medicines versus adults who had sleeve gastrectomy at the same center.
-
Gut barrier and inflammation after fast-food overfeeding in adults
This study tests whether 14 days of fast-food overfeeding can alter gut barrier function and trigger inflammation in adults who are generally healthy.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
GLP-1 weight‑loss medicine: finding who will benefit most
This study tests whether a GLP-1 drug called semaglutide helps with weight loss by changing eating behavior, to see which people it helps the most.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.